SCHEMBL670583

SCHEMBL670583

CCCCCC1C(O)CCC1CC(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.44
TBXA2R P21731 1/20 0.42
PTGFR P43088 1/20 0.42
PTGER2 P43116 1/20 0.42
ALDH1A1 P00352 3/20 0.38
AKR1B1 P15121 1/20 0.35
GPR84 Q9NQS5 7/20 0.34
PPARG P37231 6/20 0.34
PPARD Q03181 6/20 0.34
PPARA Q07869 6/20 0.34
HDAC11 Q96DB2 5/20 0.34
TSHR P16473 4/20 0.34
TLR2 O60603 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
FABP4 P15090 2/20 0.34
PTPN1 P18031 2/20 0.34
SLC22A6 Q4U2R8 1/20 0.34
SLC22A8 Q8TCC7 1/20 0.34
MEN1 O00255 1/20 0.34
ESR1 P03372 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18853790 1.00 ALOX5 (0.44) ALOX5TBXA2RPTGFRPTGER2ALDH1A1
SCHEMBL8672151 1.00 ALOX5 (0.44) ALOX5TBXA2RPTGFRPTGER2ALDH1A1
SCHEMBL8673306 1.00 ALOX5 (0.44) ALOX5TBXA2RPTGFRPTGER2ALDH1A1
SCHEMBL8674597 1.00 ALOX5 (0.44) ALOX5TBXA2RPTGFRPTGER2ALDH1A1
SCHEMBL1054958 1.00 ALOX5 (0.44) ALOX5TBXA2RPTGFRPTGER2ALDH1A1
SCHEMBL8676301 1.00 ALOX5 (0.44) ALOX5TBXA2RPTGFRPTGER2ALDH1A1
SCHEMBL8676435 1.00 ALOX5 (0.44) ALOX5TBXA2RPTGFRPTGER2ALDH1A1
SCHEMBL22002778 0.98 ALOX5 (0.46) ALOX5TBXA2RPTGFRPTGER2ALDH1A1
SCHEMBL22002780 0.98 ALOX5 (0.46) ALOX5TBXA2RPTGFRPTGER2ALDH1A1
SCHEMBL18088611 0.98 ALOX5 (0.46) ALOX5TBXA2RPTGFRPTGER2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 319 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12256733-B2 Antimicrobial mixture containing 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one and an acid or silver-based compound, and cosmetic composition containing same L'OREAL (FR) 2025-03-25 US claimed
CN-119632865-A Composition for cleaning keratin materials 莱雅公司 2025-03-18 CN claimed
CN-115477581-B Preparation method of high cis methyl dihydrojasmonate 安徽金禾合成材料研究院有限公司 2024-11-05 CN claimed
EP-3257376-B1 CONTROL AND REPELLENCY OF BED BUGS BEDOUKIAN RES INC (US) 2024-10-16 EP claimed
CN-113873988-B Composition for cleaning keratin materials 莱雅公司 2023-10-03 CN claimed
US-20230065230-A1 ANTIMICROBIAL MIXTURE CONTAINING 4-(3-ETHOXY-4-HYDROXYPHENYL)BUTAN-2-ONE AND AN ACID OR SILVER-BASED COMPOUND, AND COSMETIC COMPOSITION CONTAINING SAME L'OREAL (FR) 2023-03-02 US claimed
CN-113873988-A Composition for cleaning keratin materials 莱雅公司 2021-12-31 CN claimed
EP-3897144-A1 ANTIMICROBIAL MIXTURE CONTAINING 4-(3-ETHOXY-4-HYDROXYPHENYL)BUTAN-2-ONE AND AN ACID OR SILVER-BASED COMPOUND, AND COSMETIC COMPOSITION CONTAINING SAME L'OREAL (FR) 2021-10-27 EP claimed
CN-113395957-A Composition for cleaning keratin materials 莱雅公司 2021-09-14 CN claimed
CN-113163759-A Antimicrobial mixture containing 4- (3-ethoxy-4-hydroxyphenyl) butan-2-one and acid or silver-based compound and cosmetic composition containing the same 莱雅公司 2021-07-23 CN claimed
WO-2011000903-A2 COSMETIC USE OF A JASMONIC ACID DERIVATIVE FOR TREATING THE HAIR AND THE SCALP L'OREAL (FR) 2011-01-06 WO claimed
EP-2223680-A2 Combination of monosaccharides and exfoliating agents and its cosmetic use L'Oréal (FR) 2010-09-01 EP claimed
US-20100179222-A1 COMPOSITIONS COMPRISING JASMONIC ACID DERIVATIVES AND USE OF THESE DERIVATIVES L'OREAL S.A. 2010-07-15 US claimed
US-20100168041-A1 COMBINATION OF MONOSACCHARIDES AND DESQUAMATING AGENTS, AND USE THEREOF L'OREAL (FR) 2010-07-01 US claimed
US-20090252697-A1 METHOD FOR PERMANENTLY RESHAPING KERATIN FIBERS WITH AN ACID PRE-TREATING COMPOSITION L'OREAL S.A. (FR) 2009-10-08 US claimed
US-20090035294-A1 LIPOPOLYSACCHARIDE FRACTIONS OF VITREOSCILLA FILIFORMIS USEFUL FOR STIMULATING THE SYNTHESIS OF ANTI-MICROBIAL PEPTIDES OF THE SKIN L'OREAL (FR) 2009-02-05 US claimed
US-20080119527-A1 Composition for combating the localized hyperpigmentation of dark skin L'OREAL (FR) 2008-05-22 US claimed
US-20040029839-A1 Compositions comprising jasmonic acid derivatives and use of these derivatives L'OREAL S.A. (FR) 2004-02-12 US claimed
EP-1333021-A2 Compositions containing derivatives of jasmonic acid and their use for stimulating skin peeling L'OREAL (FR) 2003-08-06 EP claimed
EP-0715615-B1 METHOD FOR PREPARING (+)-(1R)-CIS-3-OXO-2-PENTYL-1-CYCLOPENTANEACETIC ACID FIRMENICH & CIE (CH) 1998-10-07 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040029839-A1 Compositions comprising jasmonic acid derivatives and use of these derivatives CBR1, CBR3, DECR1 ALOX5 72/4885TBXA2R 608/4885PTGFR 814/4885
US-20100179222-A1 COMPOSITIONS COMPRISING JASMONIC ACID DERIVATIVES AND USE OF THESE DERIVATIVES CBR1, CBR3, DECR1 ALOX5 46/4885TBXA2R 574/4885PTGFR 950/4885
US-20230065230-A1 ANTIMICROBIAL MIXTURE CONTAINING 4-(3-ETHOXY-4-HYDROXYPHENYL)BUTAN-2-ONE AND AN ACID OR SILVER-BASED COMPOUND, AND COSMETIC COMPOSITION CONTAINING SAME KRT18, CUTA, EBP ALOX5 3760/4885TBXA2R 4857/4885PTGFR 4391/4885
US-20090252697-A1 METHOD FOR PERMANENTLY RESHAPING KERATIN FIBERS WITH AN ACID PRE-TREATING COMPOSITION KRT18, CUTA, COL14A1 ALOX5 2326/4885TBXA2R 4884/4885PTGFR 3154/4885
US-20090035294-A1 LIPOPOLYSACCHARIDE FRACTIONS OF VITREOSCILLA FILIFORMIS USEFUL FOR STIMULATING THE SYNTHESIS OF ANTI-MICROBIAL PEPTIDES OF THE SKIN CUTA, LRBA, LTA ALOX5 596/4885TBXA2R 1512/4885PTGFR 2543/4885
US-20100168041-A1 COMBINATION OF MONOSACCHARIDES AND DESQUAMATING AGENTS, AND USE THEREOF MAN2A1, MANBA, DPM1 ALOX5 600/4885TBXA2R 4106/4885PTGFR 4280/4885
US-12256733-B2 Antimicrobial mixture containing 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one and an acid or silver-based compound, and cosmetic composition containing same KRT18, CUTA, EBP ALOX5 3760/4885TBXA2R 4857/4885PTGFR 4391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.